SCHEMBL24076322

SCHEMBL24076322

COCCn1nc(N)ccc1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MPO P05164 1/20 0.40
▸ KDM4E B2RXH2 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ ALDH1A1 P00352 5/20 0.37
▸ PDE4A P27815 3/20 0.36
▸ PDE4B Q07343 3/20 0.36
▸ PDE4C Q08493 3/20 0.36
▸ PDE4D Q08499 3/20 0.36
▸ POLB P06746 1/20 0.36
▸ PTGS2 P35354 1/20 0.35
▸ TDP1 Q9NUW8 2/20 0.35
▸ LMNA P02545 2/20 0.35
▸ HCAR3 P49019 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.34
▸ ALOX15 P16050 1/20 0.34
▸ CDK4 P11802 1/20 0.33
▸ CCND1 P24385 1/20 0.33
▸ CCND2 P30279 1/20 0.33
▸ CCND3 P30281 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL30168555 0.98 MPO (0.39) MPOKDM4EMEN1KMT2AALDH1A1
SCHEMBL25746400 0.81 MPO (0.41) MPOKDM4EMEN1KMT2AALDH1A1
SCHEMBL31366245 0.79 MPO (0.40) MPOKDM4EMEN1KMT2AALDH1A1
SCHEMBL24076248 0.79 KDM4E (0.44) MPOKDM4EMEN1KMT2AALDH1A1
SCHEMBL24246975 0.78 MPO (0.39) MPOKDM4EMEN1KMT2AALDH1A1
SCHEMBL30949211 0.78 KMT2A (0.41) MPOKDM4EMEN1KMT2AALDH1A1
SCHEMBL24077090 0.77 MPO (0.38) MPOKDM4EMEN1KMT2AALDH1A1
SCHEMBL24077344 0.76 ADRA1A (0.37) KDM4EALDH1A1
SCHEMBL104896 0.76 GAA (0.34) KDM4EKMT2AALDH1A1PTGS2LMNA
SCHEMBL3650533 0.76 HCAR3 (0.44) MPOKDM4EMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230202989-A1 COMPOUNDS JANSSEN PHARMACEUTICA NV (BE) 2023-06-29 — — US disclosed
US-20230202989-A1 COMPOUNDS JANSSEN PHARMACEUTICA NV (BE) 2023-06-29 — — US disclosed
WO-2021239885-A1 COMPOUNDS JANSSEN PHARMACEUTICA NV (BE) 2021-12-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230202989-A1 COMPOUNDS NLRP3, NLRP1, IL1B MPO 347/4885KDM4E 3777/4885MEN1 1965/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback